Followers | 839 |
Posts | 120670 |
Boards Moderated | 13 |
Alias Born | 09/05/2002 |
Tuesday, January 11, 2022 1:45:08 PM
https://investors.vir.bio/static-files/7ecf45fb-6918-4cf8-9a02-b8c12183ca4f
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Recent VIR News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/05/2024 10:51:48 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/05/2024 09:23:50 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/04/2024 09:09:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2024 08:20:26 PM
- Vir Biotechnology Reports Third Quarter 2024 Financial Results and Provides Corporate Update • Business Wire • 10/31/2024 08:05:00 PM
- Vir Biotechnology to Provide Business Update and Report Third Quarter 2024 Financial Results on October 31, 2024 • Business Wire • 10/17/2024 08:30:00 PM
- Vir Biotechnology Announces Clinical Advances Across Hepatitis Delta and Hepatitis B Programs at AASLD’s The Liver Meeting® 2024 • Business Wire • 10/15/2024 12:16:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 10/03/2024 09:11:54 PM
- Vir Biotechnology to Participate in the H.C. Wainwright 5th Annual Viral Hepatitis Virtual Conference • Business Wire • 10/03/2024 08:00:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 10/02/2024 04:09:07 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 10/02/2024 04:07:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/10/2024 08:28:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/10/2024 12:10:48 PM
- Vir Biotechnology Appoints Jason O’Byrne as Chief Financial Officer • Business Wire • 09/10/2024 12:05:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/09/2024 08:29:38 PM
- Vir Biotechnology Announces Closing of Exclusive Worldwide License Agreement With Sanofi for Multiple Potential Best-in-Class Clinical-Stage T-Cell Engagers • Business Wire • 09/09/2024 08:05:00 PM
- Vir Biotechnology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference • Business Wire • 08/22/2024 12:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/01/2024 08:43:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 08:10:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 08:08:53 PM
- Vir Biotechnology Reports Second Quarter 2024 Financial Results and Announces Strategic Restructuring to Prioritize Clinical-Stage Pipeline Opportunities • Business Wire • 08/01/2024 08:02:00 PM
- Vir Biotechnology Acts on Expanded Strategy of Powering the Immune System Through Exclusive Worldwide License Agreement with Sanofi for Multiple Potential Best-in-Class Clinical-Stage T-cell Engagers • Business Wire • 08/01/2024 08:01:00 PM
- Vir Biotechnology to Report Second Quarter 2024 Financial Results on August 1, 2024 • Business Wire • 07/18/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/16/2024 08:40:36 PM
- Vir Biotechnology Receives FDA IND Clearance and Fast Track Designation for Tobevibart and Elebsiran for the Treatment of Chronic Hepatitis Delta Infection • Business Wire • 06/26/2024 12:05:00 PM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM
Rainmaker Worldwide Inc. Announces Strategic Partnership Between Miranda Water Technologies and Fleming College • RAKR • Nov 4, 2024 12:03 PM
North Bay Resources Announces Assays up to 9.5% Copper at Murex Copper Project, British Columbia • NBRI • Nov 4, 2024 9:00 AM
Rainmaker Worldwide Inc. to Assume Direct, Non-Dealer Sales of Miranda Water Technologies in U.S. and Mexico in First Quarter of 2025 • RAKR • Nov 4, 2024 8:31 AM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM